Alejandro Hoberman
Pittsburgh, PANPI 1427021146
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,517 of the $9,556 with a category attached, or 99.6%. 3 manufacturers reported payments, led by Sanofi Pasteur Inc. at 51.0% of the total.
Across 8 payments — averaging $1194.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$5K
- GSK$3K
- Merck$2K
Across 215 payments — averaging $47,379 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$5.9M
- Merck$4M
- Photonicare Inc$328K
What the payments were for
- Consulting fees$9,517100%
- Food & beverage$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 1 | $4,872 |
| GSK | 2 | $2,500 |
| Merck | 5 | $2,184 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.